Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Cancer|January 18, 2006
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patientsIdo Wolf, Seigal Sadetzki, Hannah Kanety, et al.
The Journal of Infectious Diseases|April 15, 2010
Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancerItay Wiser, Nadav Orr, Bella Kaufman, et al.
Familial Cancer|July 18, 2009
Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populationsBella Kaufman, Yael Laitman, Jacek Gronwald, et al.
Breast (Edinburgh, Scotland)|November 25, 2019
Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?Rinat Bernstein-Molho, Bella Kaufman, Merav A Ben David, et al.
Oncology|April 18, 2012
First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA studyChristoph Thomssen, Jean-Yves Pierga, Kathleen I Pritchard, et al.
Cancer|December 14, 2007
Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based studyIdo Wolf, Noa Ben-Baruch, Ronnie Shapira-Frommer, et al.
Breast Cancer Research and Treatment|January 31, 2014
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancerDorit Pud, Gil Har-Zahav, Yael Laitman, et al.
The Lancet. Oncology|April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II studyBella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation CarriersRinat Bernstein-Molho, Yael Laitman, Shira Galper, et al.
Breast Cancer Research and Treatment|November 2, 2011
Epigenetic silencing of the tumor suppressor klotho in human breast cancerTami Rubinek, Michal Shulman, Shira Israeli, et al.
Pageof 11